Cargando…

Molecular and Clinical Characterization of a Novel Prognostic and Immunologic Biomarker FAM111A in Diffuse Lower-Grade Glioma

BACKGROUND: Family with sequence similarity 111 member A (FAM111A), as a replication factor required for proliferating cell nuclear antigen (PCNA) loading, has been demonstrated a possible association with carcinogenesis. However, the role of FAM111A in lower-grade glioma (LGG) remains unclear. We a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Xiaoshuai, Ding, Feng, Gao, Jiajia, Huang, Xiaoming, Liu, Wenqing, Wang, Yunda, Liu, Qian, Xin, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649369/ https://www.ncbi.nlm.nih.gov/pubmed/33194678 http://dx.doi.org/10.3389/fonc.2020.573800

Ejemplares similares

Immune-Related Gene SERPINE1 Is a Novel Biomarker for Diffuse Lower-Grade Gliomas via Large-Scale Analysis
por: Huang, Xiaoming, et al.
Publicado: (2021)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

Classification of diffuse lower‐grade glioma based on immunological profiling
por: Wu, Fan, et al.
Publicado: (2020)

Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes
por: Guo, Hong, et al.
Publicado: (2018)

Classification of Adverse Events Following Surgery in Patients With Diffuse Lower-Grade Gliomas
por: Gómez Vecchio, Tomás, et al.
Publicado: (2021)

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma
por: Lin, Li, et al.
Publicado: (2021)

Proposed Cellular Function of the Human FAM111B Protein and Dysregulation in Fibrosis and Cancer
por: Arowolo, Afolake, et al.
Publicado: (2022)

Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma
por: Xu, Shenbin, et al.
Publicado: (2021)

Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023)

Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients
por: Guo, Jin-Cheng, et al.
Publicado: (2021)

Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs
por: Wen, Jing, et al.
Publicado: (2020)

Development and Validation of a Novel Prognostic Model for Lower-Grade Glioma Based on Enhancer RNA-Regulated Prognostic Genes
por: Tian, Wei, et al.
Publicado: (2022)

The Prognostic and Immunological Value of Guanylate-Binding Proteins in Lower-Grade Glioma: Potential Markers or Not?
por: Liu, Zhuang, et al.
Publicado: (2021)

Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma
por: Qiu, Huaide, et al.
Publicado: (2021)

Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients
por: Lei, Kunjian, et al.
Publicado: (2021)

Identifying α-KG-dependent prognostic signature for lower-grade glioma based on transcriptome profiles
por: Zhang, Tan, et al.
Publicado: (2022)

Radiomics and Qualitative Features From Multiparametric MRI Predict Molecular Subtypes in Patients With Lower-Grade Glioma
por: Sun, Chen, et al.
Publicado: (2022)

PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas
por: Xie, Qijun, et al.
Publicado: (2022)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
por: Yin, Wen, et al.
Publicado: (2020)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas
por: Zhao, Zheng, et al.
Publicado: (2020)

Prediction of Lower Grade Insular Glioma Molecular Pathology Using Diffusion Tensor Imaging Metric-Based Histogram Parameters
por: Huang, Zhenxing, et al.
Publicado: (2021)

Management of Diffuse Low-Grade Glioma: The Renaissance of Robust Evidence
por: Brar, Karanbir, et al.
Publicado: (2020)

Fam20C Overexpression Predicts Poor Outcomes and is a Diagnostic Biomarker in Lower-Grade Glioma
por: Feng, Jing, et al.
Publicado: (2021)

Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
por: Zhang, Qiang, et al.
Publicado: (2021)

OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma
por: An, Yang, et al.
Publicado: (2020)

Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas
por: Wu, Jianing, et al.
Publicado: (2022)

Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas
por: Dong, Jiawei, et al.
Publicado: (2023)

Comprehensive Analysis of the Prognostic Value and Immune Infiltration of Butyrophilin Subfamily 2/3 (BTN2/3) Members in Pan-Glioma
por: He, Dong, et al.
Publicado: (2022)

Integrative Analysis of a Novel Eleven-Small Nucleolar RNA Prognostic Signature in Patients With Lower Grade Glioma
por: Deng, Teng, et al.
Publicado: (2021)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Prognostic and immunological role of Fam20C in pan-cancer
por: Liu, Xinpeng, et al.
Publicado: (2021)

Exploring the relationship between abnormally high expression of NUP205 and the clinicopathological characteristics, immune microenvironment, and prognostic value of lower-grade glioma
por: Liang, Wenjia, et al.
Publicado: (2023)

Radiomics Features Predict CIC Mutation Status in Lower Grade Glioma
por: Zhang, Luyuan, et al.
Publicado: (2020)

Correlation Between APOBEC3B Expression and Clinical Characterization in Lower-Grade Gliomas
por: Zhang, Hao, et al.
Publicado: (2021)

Functions and evolution of FAM111 serine proteases
por: Welter, Allison L., et al.
Publicado: (2022)

N(6) ‐methyladenosine‐modified FAM111A‐DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111A
por: Pu, Jian, et al.
Publicado: (2023)

NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma
por: Ren, Wenjun, et al.
Publicado: (2022)

Immune Characteristics and Prognosis Analysis of the Proteasome 20S Subunit Beta 9 in Lower-Grade Gliomas
por: Liu, Junzhe, et al.
Publicado: (2022)

Behavior-Oriented Nomogram for the Stratification of Lower-Grade Gliomas to Improve Individualized Treatment
por: Wei, Ruo-Lun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_05dbmqmvfnjouv2v0usta8u336